MAPT and Alzheimer disease: The profiles of EV-miRNA expression levels were recently identified from distinct body fluids, including serum, plasma, and CSF, revealing that most of the miRNAs changed in AD target genes related to APP processing, Tau phosphorylation, oxidative phosphorylation, mitochondrial dysfunction, and apoptosis [19,27,28,29,30,31,32].